{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:45Z","timestamp":1791337965727,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Liaoning Province Educational Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MSLH-035"],"award-info":[{"award-number":["2023-MSLH-035"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200713"],"award-info":[{"award-number":["82200713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.isci.2026.114839","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:47:44Z","timestamp":1769701664000},"page":"114839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted inhibition of M2 macrophages polarization via a PDC attenuates chronic pancreatitis through the PPAR\u03b1 pathway"],"prefix":"10.1016","volume":"29","author":[{"given":"Xin","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-4314","authenticated-orcid":false,"given":"Deshi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.114839_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMcp1809396","article-title":"Chronic Pancreatitis","volume":"386","author":"Vege","year":"2022","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.isci.2026.114839_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(20)31318-0","article-title":"Chronic pancreatitis","volume":"396","author":"Beyer","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.isci.2026.114839_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106508","article-title":"Macrophages: A rising star in immunotherapy for chronic pancreatitis","volume":"185","author":"Xiang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.114839_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamasurg.2023.0367","article-title":"Etiology, Diagnosis, and Modern Management of Chronic Pancreatitis: A Systematic Review","volume":"158","author":"Cohen","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.isci.2026.114839_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in Tissue Repair, Regeneration, and Fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.114839_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102920","article-title":"Macrophage phenotypic switch orchestrates the inflammation and repair\/regeneration following acute pancreatitis injury","volume":"58","author":"Wu","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.114839_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8158","article-title":"Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis","volume":"6","author":"Xue","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114839_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/17474124.2024.2355969","article-title":"Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages","volume":"18","author":"Iyer","year":"2024","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.114839_bib9","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.7150\/thno.54245","article-title":"Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation","volume":"11","author":"Xiang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.114839_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000097","article-title":"Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides","volume":"7","author":"Bj\u00f6rk","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.isci.2026.114839_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1517\/13543784.2010.514262","article-title":"The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer","volume":"19","author":"Isaacs","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.isci.2026.114839_bib12","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D0CS00556H","article-title":"Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs)","volume":"50","author":"Cooper","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.isci.2026.114839_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide-drug conjugates as effective prodrug strategies for targeted delivery","volume":"110\u2013111","author":"Wang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2026.114839_bib14","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.apsb.2023.02.013","article-title":"Research advances in peptide\u2012drug conjugates","volume":"13","author":"Gong","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.114839_bib15","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0250","article-title":"The Peptide-Drug Conjugate M1pep-Tasquinimod Ameliorates Acute Pancreatitis via Selectively Clearing M1-like Macrophages","volume":"29","author":"Guo","year":"2025","journal-title":"Biomater. Res."},{"key":"10.1016\/j.isci.2026.114839_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1526813","article-title":"Targeted inhibitors of S100A9 alleviate chronic pancreatitis by inhibiting M2 macrophage polarization via the TAOK3-JNK signaling pathway","volume":"16","author":"Tao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114839_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910545","article-title":"The Role of PPAR Alpha in the Modulation of Innate Immunity","volume":"22","author":"Grabacka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114839_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00888-x","article-title":"Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling","volume":"29","author":"Lin","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.isci.2026.114839_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3524","article-title":"Knockdown of AK142426 suppresses M2 macrophage polarization and inflammation in peritoneal fibrosis via binding to c-Jun","volume":"25","author":"Shao","year":"2023","journal-title":"J. Gene Med."},{"key":"10.1016\/j.isci.2026.114839_bib20","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2016.66.9697","article-title":"Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer","volume":"34","author":"Sternberg","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.114839_bib21","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1093\/annonc\/mdx487","article-title":"A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy","volume":"28","author":"Fizazi","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.114839_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.bjc.6605322","article-title":"Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer","volume":"101","author":"Bratt","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.114839_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.114839_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115135","article-title":"Old drugs with new applications: Tofacitinib-mediated inhibition of M1-like macrophage polarization in acute pancreatitis by the JAK\/STAT and emerging NOD-like receptor pathways","volume":"162","author":"Dai","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.114839_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215969","article-title":"Drug conjugate-based anticancer therapy - Current status and perspectives","volume":"552","author":"Yang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.114839_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acs.jmedchem.2c01791","article-title":"Degrader-Antibody Conjugates: Emerging New Modality","volume":"66","author":"Hong","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114839_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-021-00868-x","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.114839_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115717","article-title":"Advances in targeted therapy for pancreatic cancer","volume":"168","author":"Xing","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.114839_bib29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1021\/acs.jmedchem.3c01835","article-title":"Peptide-Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics","volume":"67","author":"Dean","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114839_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116119","article-title":"Peptide-drug conjugates: A new paradigm for targeted cancer therapy","volume":"265","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114839_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.tips.2021.07.001","article-title":"Peptide-drug conjugate-based novel molecular drug delivery system in cancer","volume":"42","author":"Zhu","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2026.114839_bib32","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1110\/ps.8.7.1432","article-title":"Relating structure to thermodynamics: the crystal structures and binding affinity of eight OppA-peptide complexes","volume":"8","author":"Davies","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.isci.2026.114839_bib33","doi-asserted-by":"crossref","first-page":"21001","DOI":"10.1073\/pnas.1819533116","article-title":"Mapping low-affinity\/high-specificity peptide-protein interactions using ligand-footprinting mass spectrometry","volume":"116","author":"Parker","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.114839_bib34","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1073\/pnas.92.5.1754","article-title":"Site-directed mutagenesis studies of the high-affinity streptavidin-biotin complex: contributions of tryptophan residues 79, 108, and 120","volume":"92","author":"Chilkoti","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.114839_bib35","article-title":"Research progress on unique paratope structure, antigen binding modes, and systematic mutagenesis strategies of single-domain antibodies","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114839_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00986","article-title":"Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis","volume":"8","author":"Tiller","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114839_bib37","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.7150\/thno.96641","article-title":"Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide","volume":"14","author":"El Fakiri","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.114839_bib38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.7150\/thno.15394","article-title":"Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep)","volume":"6","author":"Ngambenjawong","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.114839_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.chembiol.2020.11.002","article-title":"Systematic Activity Maturation of a Single-Domain Antibody with Non-canonical Amino Acids through Chemical Mutagenesis","volume":"28","author":"Lindstedt","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2026.114839_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biotechadv.2007.02.003","article-title":"Isolation and affinity maturation of hapten-specific antibodies","volume":"25","author":"Sheedy","year":"2007","journal-title":"Biotechnol. Adv."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226002142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226002142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:41:30Z","timestamp":1791337290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226002142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2589004226002142"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.114839","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted inhibition of M2 macrophages polarization via a PDC attenuates chronic pancreatitis through the PPAR\u03b1 pathway","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.114839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114839"}}